Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Quality of Life in Patients <=70 Years of Age with Chronic Lymphocytic Leukemia Treated Frontline with IbrutinibRituximab Versus Fludarabine Cyclophosphamide Rituximab: Analysis from ECOG-ACRIN E1912
Quality of Life in Patients <=70 Years of Age with Chronic Lymphocytic Leukemia Treated Frontline with IbrutinibRituximab Versus Fludarabine Cyclophosphamide Rituximab: Analysis from ECOG-ACRIN E1912 Pophali, P. A., Wang, X., Zhao, F., Kay, N. E., Hanson, C. A., Thomas, M. L., O'Brien, S. M., Barrientos, J., Paietta, E. M., Leis, J. F., Zhang, C., Coutre, S., Barr, P. M., Cashen, A., Mato, A. R., Singh, A., Little, R. F., Erba, H. P., Stone, R. M., Litzow, M. R., Tallman, M. S., Shanafelt, T., Wagner, L. I. AMER SOC HEMATOLOGY. 2021View details for DOI 10.1182/blood-2021-150462
View details for Web of Science ID 000736398806032